Zentalis Pharmaceuticals IncNASDAQ:ZNTL
- LAST PRICE4.0900
- TODAY'S CHANGE (%)-0.1100 (-2.6190%)
- Bid / Lots4.0500/ 2
- Ask / Lots4.2000/ 2
- Open / Previous Close4.2400 / 4.2000
- Day Range
- 52 Week Range
- Volume3,688,754
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZNTL |
|---|---|---|
| 09:32 ET | 8071 | 4.17 |
| 09:34 ET | 1201 | 4.17 |
| 09:36 ET | 500 | 4.19 |
| 09:38 ET | 100 | 4.17 |
| 09:39 ET | 4742 | 4.1604 |
| 09:41 ET | 900 | 4.15 |
| 09:43 ET | 1665 | 4.17 |
| 09:45 ET | 200 | 4.18 |
| 09:48 ET | 38216 | 4.12 |
| 09:50 ET | 6804 | 4.13 |
| 09:52 ET | 2488 | 4.1 |
| 09:54 ET | 14854 | 4.08 |
| 09:57 ET | 1800 | 4.095 |
| 09:59 ET | 1447 | 4.08 |
| 10:01 ET | 300 | 4.09 |
| 10:03 ET | 1571 | 4.0835 |
| 10:06 ET | 1947 | 4.08 |
| 10:08 ET | 400 | 4.07 |
| 10:10 ET | 11573 | 4.0898 |
| 10:12 ET | 1569 | 4.11 |
| 10:14 ET | 500 | 4.12 |
| 10:15 ET | 651 | 4.11 |
| 10:17 ET | 443 | 4.11 |
| 10:19 ET | 4731 | 4.16 |
| 10:21 ET | 2850 | 4.15 |
| 10:24 ET | 300 | 4.16 |
| 10:26 ET | 575 | 4.15 |
| 10:28 ET | 1522 | 4.14 |
| 10:30 ET | 830 | 4.13 |
| 10:32 ET | 6937 | 4.131 |
| 10:33 ET | 1222 | 4.1015 |
| 10:35 ET | 2304 | 4.115 |
| 10:37 ET | 622 | 4.1 |
| 10:39 ET | 1600 | 4.11 |
| 10:42 ET | 1543 | 4.1 |
| 10:44 ET | 1100 | 4.1 |
| 10:46 ET | 11079 | 4.13 |
| 10:48 ET | 600 | 4.12 |
| 10:50 ET | 100 | 4.13 |
| 10:51 ET | 2684 | 4.13 |
| 10:53 ET | 1303 | 4.13 |
| 10:55 ET | 1005 | 4.13 |
| 10:57 ET | 2689 | 4.11 |
| 11:00 ET | 2272 | 4.11 |
| 11:02 ET | 1969 | 4.1 |
| 11:04 ET | 1422 | 4.07 |
| 11:06 ET | 350 | 4.06 |
| 11:08 ET | 600 | 4.06 |
| 11:09 ET | 1084 | 4.08 |
| 11:11 ET | 1053 | 4.08 |
| 11:15 ET | 8839 | 4.06 |
| 11:18 ET | 1583 | 4.07 |
| 11:22 ET | 600 | 4.06 |
| 11:24 ET | 900 | 4.08 |
| 11:27 ET | 2800 | 4.08 |
| 11:31 ET | 700 | 4.08 |
| 11:33 ET | 2249 | 4.0855 |
| 11:36 ET | 100 | 4.09 |
| 11:38 ET | 2200 | 4.08 |
| 11:40 ET | 6523 | 4.05 |
| 11:42 ET | 300 | 4.06 |
| 11:44 ET | 100 | 4.055 |
| 11:45 ET | 739 | 4.06 |
| 11:47 ET | 6052 | 4.09 |
| 11:49 ET | 850 | 4.09 |
| 11:51 ET | 1959 | 4.12 |
| 11:54 ET | 900 | 4.13 |
| 11:56 ET | 1350 | 4.13 |
| 11:58 ET | 400 | 4.13 |
| 12:00 ET | 750 | 4.13 |
| 12:02 ET | 8203 | 4.145 |
| 12:03 ET | 1679 | 4.13 |
| 12:05 ET | 200 | 4.13 |
| 12:07 ET | 3002 | 4.11 |
| 12:09 ET | 300 | 4.105 |
| 12:12 ET | 1950 | 4.1007 |
| 12:14 ET | 735 | 4.11 |
| 12:16 ET | 2176 | 4.08 |
| 12:18 ET | 1100 | 4.08 |
| 12:20 ET | 2949 | 4.09 |
| 12:21 ET | 312 | 4.09 |
| 12:23 ET | 500 | 4.1 |
| 12:27 ET | 1452 | 4.1 |
| 12:30 ET | 200 | 4.11 |
| 12:32 ET | 5543 | 4.12 |
| 12:34 ET | 4404 | 4.13 |
| 12:36 ET | 600 | 4.135 |
| 12:38 ET | 224 | 4.13 |
| 12:39 ET | 2236 | 4.11 |
| 12:41 ET | 9089 | 4.12 |
| 12:43 ET | 100 | 4.12 |
| 12:45 ET | 1300 | 4.12 |
| 12:48 ET | 3883 | 4.13 |
| 12:50 ET | 600 | 4.125 |
| 12:52 ET | 3287 | 4.125 |
| 12:54 ET | 200 | 4.12 |
| 12:56 ET | 2769 | 4.11 |
| 12:57 ET | 423 | 4.115 |
| 12:59 ET | 2133 | 4.11 |
| 01:01 ET | 7415 | 4.09 |
| 01:03 ET | 1119 | 4.09 |
| 01:06 ET | 801 | 4.09 |
| 01:08 ET | 1110 | 4.09 |
| 01:10 ET | 700 | 4.1 |
| 01:12 ET | 1200 | 4.1 |
| 01:14 ET | 366 | 4.1 |
| 01:15 ET | 1322 | 4.1 |
| 01:17 ET | 548 | 4.095 |
| 01:19 ET | 200 | 4.09 |
| 01:21 ET | 600 | 4.095 |
| 01:24 ET | 2604 | 4.09 |
| 01:26 ET | 731 | 4.09 |
| 01:28 ET | 8176 | 4.06 |
| 01:30 ET | 1781 | 4.05 |
| 01:32 ET | 1114 | 4.069 |
| 01:33 ET | 50928 | 4.05 |
| 01:35 ET | 887 | 4.04 |
| 01:37 ET | 1092 | 4.04 |
| 01:39 ET | 400 | 4.05 |
| 01:42 ET | 600 | 4.04 |
| 01:44 ET | 1156 | 4.03 |
| 01:46 ET | 10982 | 4.03 |
| 01:48 ET | 400 | 4.035 |
| 01:50 ET | 300 | 4.035 |
| 01:51 ET | 1374 | 4.025 |
| 01:53 ET | 2817 | 4.04 |
| 01:55 ET | 700 | 4.045 |
| 01:57 ET | 792 | 4.055 |
| 02:00 ET | 974 | 4.06 |
| 02:02 ET | 1640 | 4.06 |
| 02:04 ET | 1300 | 4.06 |
| 02:06 ET | 1327 | 4.055 |
| 02:08 ET | 1288 | 4.06 |
| 02:09 ET | 2811 | 4.07 |
| 02:11 ET | 661 | 4.065 |
| 02:13 ET | 1738 | 4.07 |
| 02:15 ET | 300 | 4.08 |
| 02:18 ET | 5011 | 4.0925 |
| 02:20 ET | 300 | 4.085 |
| 02:22 ET | 800 | 4.09 |
| 02:24 ET | 2155 | 4.09 |
| 02:26 ET | 4750 | 4.09 |
| 02:27 ET | 811 | 4.1 |
| 02:29 ET | 800 | 4.1 |
| 02:31 ET | 400 | 4.1 |
| 02:33 ET | 1970 | 4.1 |
| 02:36 ET | 904 | 4.11 |
| 02:38 ET | 3081 | 4.1025 |
| 02:40 ET | 800 | 4.105 |
| 02:42 ET | 611 | 4.105 |
| 02:44 ET | 2531 | 4.11 |
| 02:45 ET | 300 | 4.11 |
| 02:47 ET | 1250 | 4.105 |
| 02:49 ET | 8637 | 4.095 |
| 02:51 ET | 400 | 4.095 |
| 02:54 ET | 386 | 4.095 |
| 02:56 ET | 4583 | 4.09 |
| 02:58 ET | 600 | 4.09 |
| 03:00 ET | 2288 | 4.09 |
| 03:02 ET | 300 | 4.08 |
| 03:03 ET | 3947 | 4.085 |
| 03:05 ET | 1565 | 4.085 |
| 03:07 ET | 1002 | 4.085 |
| 03:09 ET | 800 | 4.085 |
| 03:12 ET | 5329 | 4.07 |
| 03:14 ET | 561 | 4.06 |
| 03:16 ET | 985 | 4.0614 |
| 03:18 ET | 5442 | 4.065 |
| 03:20 ET | 2181 | 4.04 |
| 03:21 ET | 5270 | 4.05 |
| 03:23 ET | 514 | 4.05 |
| 03:25 ET | 6030 | 4.045 |
| 03:27 ET | 400 | 4.045 |
| 03:30 ET | 200 | 4.05 |
| 03:32 ET | 10765 | 4.03 |
| 03:34 ET | 1713 | 4.015 |
| 03:36 ET | 10301 | 4.035 |
| 03:38 ET | 4293 | 4.032 |
| 03:39 ET | 3451 | 4.045 |
| 03:41 ET | 2871 | 4.045 |
| 03:43 ET | 3641 | 4.055 |
| 03:45 ET | 11877 | 4.055 |
| 03:48 ET | 7664 | 4.065 |
| 03:50 ET | 6556 | 4.08 |
| 03:52 ET | 39297 | 4.095 |
| 03:54 ET | 11711 | 4.1 |
| 03:56 ET | 15390 | 4.11 |
| 03:57 ET | 18949 | 4.1 |
| 03:59 ET | 11866 | 4.09 |
Today
Jun 26, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL, from 2:31PM ET on Wednesday Jun 26, 2024 by Dow Jones
2:31PM ET on Wednesday Jun 26, 2024 by Dow Jones
Jun 24, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL, from 3:56PM ET on Monday Jun 24, 2024 by Dow Jones
3:56PM ET on Monday Jun 24, 2024 by Dow Jones
Jun 21, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL, from 5:20PM ET on Friday Jun 21, 2024 by Dow Jones
5:20PM ET on Friday Jun 21, 2024 by Dow Jones
Jun 20, 2024
DJ Zentalis Pharmaceuticals Cut to Neutral From Buy by UBS, from 12:46PM ET on Thursday Jun 20, 2024 by Dow Jones
12:46PM ET on Thursday Jun 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentalis Pharmaceuticals Inc | 295.4M | -1.2x | --- |
ALX Oncology Holdings Inc | 306.3M | -1.6x | --- |
Atea Pharmaceuticals Inc | 283.8M | -1.7x | --- |
Korro Bio Inc | 310.2M | -0.8x | --- |
Nautilus Biotechnology Inc | 278.1M | -4.3x | --- |
Kyverna Therapeutics Inc | 313.4M | -4.3x | --- |
Company Information
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The Company is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The Company is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Contact Information
- Headquarters
- 10275 Science Center Drive, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-263-4333
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Johnson
- President, Executive Director
- Cam Gallagher
- President, Chief Executive Officer, Director
- Kimberly Blackwell
- Chief Financial Officer, Treasurer
- Melissa Epperly
- Chief Operating Officer
- Iris Roth
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $295.4M |
|---|---|
Revenue (TTM) | $40.6M |
Shares Outstanding | 71.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.68 |
EPS | $-3.36 |
Book Value | $6.18 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -639.35% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
